The Board of Directors of Boston Scientific Corporation (NYSE:BSX) authorized a share repurchase program on January 29, 2013. Under the program, the company will repurchase up to $1 billion worth of shares of the company's common stock.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
77.65 USD | +0.99% | +1.64% | +34.32% |
Jul. 12 | Mizuho Adjusts Price Target on Boston Scientific to $100 From $90 | MT |
Jul. 10 | Citigroup Adjusts Price Target on Boston Scientific to $90 From $87 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.32% | 114B | |
+3.26% | 209B | |
+6.55% | 183B | |
+31.66% | 158B | |
+5.13% | 67.29B | |
+19.33% | 54.83B | |
-3.30% | 46.88B | |
-4.84% | 38.58B | |
+3.83% | 36.65B | |
+19.07% | 30.09B |
- Stock Market
- Equities
- BSX Stock
- News Boston Scientific Corporation
- Boston Scientific Corporation announces an Equity Buyback for $1,000 million worth of its shares.